SEC Form 4 · accession 0001390478-16-000106
SELLAS Life Sciences Group, Inc. · SLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mary Ann Gray
Director
Period of report
Apr 25, 2016
Accepted (ET)
Apr 28, 2016 · 6:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001390478
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $1.40 | Apr 25, 2016 | A | 200,000 | A | — | Apr 25, 2026 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1Granted pursuant to the Issuer's 2007 Incentive Plan.
- F2This stock option vests in four equal, quarterly installments over a period of one year beginning three months after April 25, 2016.